Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

Actions
  • Price (USD)1.31
  • Today's Change0.00 / 0.00%
  • Shares traded312.61k
  • 1 Year change+8.94%
  • Beta0.6203
Data delayed at least 20 minutes, as of Apr 25 2024 14:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on $1000

1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+10.83%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+30.87%
Morningstar's Benchmark(Russell 2000 Biotech Growth) 50.000% + ( Nasdaq Biotechnology Index) 50.000%--

Key statistics

As of last trade RTW Biotech Opportunities Ltd (RTW:LSE) traded at 1.31, -8.39% below its 52-week high of 1.43, set on Jan 31, 2024.
52-week range
Today
1.05Nov 02 20231.43Jan 31 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding385.29m
Market cap510.24m USD
Total assets751.31m USD
Total expense ratio1.97%
High1.31
Low1.31
Previous close1.31
Average volume565.57k
YTD Change-6.60%
Beta0.6203
Diluted NAV (est)1.95
Diluted NAV (last pub)1.95
Premium/Discount-32.82%
Net Gearing0.00%
Data delayed at least 20 minutes, as of Apr 25 2024 14:01 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.